Xiel Limited has been acquired by MIS Healthcare
December 2024 — MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Xiel Limited is a specialist in nuclear medicine and radiotherapy, serving the UK and Irish markets. The company primarily provides nuclear medicine and radiotherapy capital and services to hospitals, universities, research institutes and private companies, tailoring their offerings to meet specific customer needs.
MIS Healthcare is a UK-based exclusive distributor for world-leading medical manufacturers offering state-of-the-art products, including high-end medical imaging diagnostic equipment, PACS/RIS, medical consumables and diagnostic instruments. The company aims to become a leading specialist in the diagnostic imaging, radiology and oncology markets.
Our role in the transaction
Oaklins S&W, one of Oaklins’ member firms in the UK, served as the corporate finance advisor to the shareholders of Xiel Limited.
Talk to the deal team
Related deals
Be-Cloud has been acquired by PSG Equity
Be-Cloud, backed by B&Capital since 2021, has been acquired by PSG Equity, a leading growth equity firm specializing in software and technology-enabled services. The transaction marks the full exit of B&Capital and the reinvestment of Be-Cloud’s founders, Lenny and Sébastien Vercruysse, alongside PSG Equity.
Learn moreMattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild
Mattina Holding S.A. (DVC Partners) has sold a 5% stake in Italian company Gens Aurea S.p.A. through an accelerated bookbuild, raising approximately US$69.96 million.
Learn moreCibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn more